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Abstract 
Advances in neuroimaging have enabled greater understanding of the progression of cerebral 
degenerative processes associated with ageing-related dementias.  Leukoaraiosis or rarefied 
white matter (WM) originally described on computed tomography is one of the most prominent 
changes which occurs in older age.  White matter hyperintensities (WMH) evident on magnetic 
resonance imaging have become commonplace to describe WM changes in relation to cognitive 
dysfunction, types of stroke injury, cerebral small vessel disease and neurodegenerative 
disorders including Alzheimer’s disease.  Substrates of WM degeneration collectively include 
myelin loss, axonal abnormalities, arteriolosclerosis and parenchymal changes resulting from 
lacunar infarcts, microinfarcts, microbleeds and perivascular spacing.  WM cells incorporating 
astrocytes, oligodendrocytes, pericytes and microglia are recognised as key cellular components 
of the gliovascular unit.  They respond to ongoing pathological processes in different ways 
leading to disruption of the gliovascular unit.  The most robust alterations involve 
oligodendrocyte loss and astrocytic clasmatodendrosis with displacement of the water channel 
protein, aquaporin 4.  These modifications likely precede arteriolosclerosis and capillary 
degeneration and involve tissue oedema, breach of the blood-brain barrier (BBB) and induction 
of a chronic hypoxic state in the deep WM.  Several pathophysiological mechanisms are 
proposed to explain how WM changes commencing with haemodynamic changes within the 
vascular system impact on cognitive dysfunction.   Animal models simulating cerebral 
hypoperfusion in man have paved the way for several translational opportunities.  Various 
compounds with variable efficacies have been tested to reduce oxidative stress, inflammation 
and BBB damage in the WM.  Our review demonstrates that WM degeneration encompasses 
multiple substrates and therefore more than one pharmacological approach is necessary to 
preserve axonal function and prevent cognitive impairment. 
 
 
Key words: Ageing, astrocytes, clasmatodendrocyte, blood brain barrier, cognitive impairment, 
post-stroke dementia, stroke, vascular dementia, white matter 
 
Abbreviations used:  AD, Alzheimer’s disease; APP, amyloid precursot protein;  BBB, blood-
brain barrier; BCAS, bilateral carotid artery stenosis; BMP4, bone-marrow protein 4; CADASIL, 
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy;  
CFAS, Cognitive Function in Ageing Study;  DTI, diffusion tensor imaging; DWML, deep 
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white matter lesions; GFAP, glial fibrillary acidic protein; MAG, myelin-associated 
glycoprotein; MBP, myelin basic protein;  MOG, myelin oligodendrocyte glycoprotein, dMBP; 
degenerating form of MBP; MRI, magnetic resonance imaging; OPC, oligodendrocyte precursor 
cell; PLP, proteolipid protein; PWML, periventricular white matter lesions; SVD, small vessels 
disease; VCI, vascular cognitive impairment; VaD, vascular dementia; WM, white matter; 
WMH, white matter hyperintensities; WML, white matter lesions 
 
 
In this Issue: 
The item will contain Figure 3 with text:  In this review, we discuss disintegration of the cellular 
components of the gliovascular unit in the white matter.  This has consequences on blood-brain 
barrier integrity and is a strong correlate of white matter damage associated with cognitive 
impairment.  Animal models of cerebral hypoperfusion replicate several features of white matter 
changes in man.  They have been valuable in identifying various agents which target oxidative 
stress, inflammation and BBB damage.   
Please see attached TIFF file.
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Introduction 
Ageing related cognitive impairment involves multiple substrates affecting brain structure and 
function.  Neuroimaging evidence shows that white matter (WM) changes are associated with 
various clinical, sensorimotor, lifestyle, behavioural and cognitive abnormalities, particularly 
related to the small vessel disease (SVD) syndrome (Pantoni 2010).  Imaging evidence reveals 
that reduced brain volumes, medial temporal lobe atrophy and cortical thinning are related to 
cognitive dysfunction in both neurodegenerative and cerebrovascular diseases.  For example, 
several imaging studies have found an association between white matter lesions (WML) and 
global brain atrophy, but it is not clear if this association is independent of shared risk factors 
(Appelman et al. 2009, Schmidt et al. 2005).  Similarly, lacunar infarcts and microstructural 
damage in the WM tracts connecting to the cortex may lead to focal cortical thinning with 
implications for the structural and functional reorganization after stroke (Duering et al. 2012).   
WM changes also contribute to disruption of fronto-subcortical circuits and cortico-cortical 
disconnectivity (Benjamin et al. 2014).    
In recent years, the cerebral WM has become an important focus for investigation of 
mechanisms in brain ageing and dementia.  This is consistent with the fact that age per se is an 
important contributor to the progression of WM pathology (Gouw et al. 2008b), which relates to 
increased white matter hyperintensities (WMH) volume and risk factors associated with 
disability, dementia and death (Inzitari et al. 2009).   Chronic cerebral hypoperfusion leads to 
diffuse WM changes, which are strongly correlated with cognitive impairment and depression as 
well as gait disturbance (Poggesi et al. 2011, Longstreth et al. 1996).  Moreover, carotid artery 
stenosis is an important risk factor for cerebral WM disease (Kandiah et al. 2014, Baradaran et 
al. 2016) and relates to WM damage and cognitive dysfunction (Tomimoto et al. 2004, Jokinen 
et al. 2007, Ryberg et al. 2011) apparent in subcortical ischemic vascular dementia (VaD) 
(Shibata et al. 2004).   Neuropathological examination, albeit with limited sampling has on the 
whole substantiated various findings identifying the relationship between cerebral and vascular 
atrophy and cognitive impairment or dementia.   The utility of post-mortem imaging of 
neuropathological specimens, particularly with magnetic resonance imaging (MRI) has further 
complemented and enabled better understanding of the pathophysiology of the WM (Gouw et al. 
2008a, Fazekas et al. 1991, Fernando et al. 2004, McAleese et al. 2013).   
In this review, we focus on the pathophysiology of the WM in the context of common 
dementias.  We draw on different neuroimaging and neuropathological studies to highlight 
specific pathologies within the WM that are associated with normal ageing and vascular 
cognitive disorders in particular.  Animal models of cerebral hypoperfusion have also enabled 
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better understanding on how different cellular and molecular components of the WM alter 
during ageing-related cerebral hypoperfusion.   Although changes in several substrates likely 
contribute to cognitive impairment, clearly the integrity of the blood-brain barrier (BBB) is an 
important factor (Wardlaw et al. 2013a, Hainsworth et al. 2017).  The intricately linked 
gliovascular unit appears a key factor in WM degeneration associated with dementia in which 
WM changes are prominent, particularly VaD.   
 
Neuroimaging in man  
Leukoaraiosis or rarefied white matter was first described as a decreased signal on computed 
tomography to denote diffuse WM changes (Hachinski et al. 1987).  More recently, WMH on 
T2- weighted or FLAIR MRI have been widely analysed to primarily relate to the presence of 
cerebral SVD (Wardlaw et al. 2013b) (Figure 1).  WMH are also common in neurodegenerative 
dementias including Alzheimer’s disease (AD) (Prins & Scheltens 2015, Gouw et al. 2008a, 
Frings et al. 2014).  Their presence in neurodegenerative diseases could reflect pathological 
processes other than those involved in SVD.   However, the prevalence and volumes of WMH as 
seen on brain T2-weighted MRI increase exponentially with age (de Leeuw et al. 2001).   In the 
general population, the prevalence of WMH or WMLs ranges from 11 to 21% in adults aged 64 
years and increases to 94% at age 82.  Women tend to have a higher degree of WMH than men 
(Sachdev et al. 2016).  WMH are more common and extensive in patients with cardiovascular 
risk factors and symptomatic cerebrovascular disease.  In a meta-analysis study (Debette & 
Markus 2010), WMH were reported to be linked to an increased risk of stroke, dementia and 
death.  These risks are increased in the general population although not consistently in high risk 
subjects with a history of stroke or vascular disease.  The heritability of WMH has been shown 
to be as high as 45-73% in some cohorts (Atwood et al. 2004, Turner et al. 2004, Adib-Samii et 
al. 2015).  Recent genome-wide association studies have even identified specific loci on 
chromosome 17 (Fornage et al. 2011, Adib-Samii et al. 2013).   The high heritability of both 
periventricular white matter hyperintensities (PWMH) as well as deep white matter 
hyperintensities (DWMH) has also been recognised (Sachdev et al. 2016).  WMH volumes and 
their confluency appear to be relevant predictors of subsequent progression of WM damage 
(Schmidt et al. 1999, Ovbiagele & Saver 2006).  In an attempt to explain WM degenerative 
mechanisms, WM changes within the centrum semiovale have been anatomically designated as 
periventricular white matter (PWML) and deep white matter lesions (DWML) or deep 
subcortical lesions.   DWML have greater tendency to become confluent and may extend 
periventricularly such that further regional classification of the WM can be difficult.   
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WMHs are also associated with a more rapid or greater decline in global cognitive performance, 
executive function, and processing speed (Bolandzadeh et al. 2012, Prins & Scheltens 2015).   
Other studies report an association between periventricular WMH and executive dysfunction or 
slowing of processing speed, than subcortical WMH  (Duering et al. 2014).  We previously 
reported that in older stroke survivors, cognitive processing speed and performance as measures 
of attention were significantly associated with whole WMH volume in the frontal lobe, whereas 
memory impairment was associated with volumes of WMH in the temporal lobe (Burton et al. 
2004).   In accord with this PWML and DWML sub-regions have been associated with different 
clinical phenotypes (Kee Hyung et al. 2011).   However, there is some controversy whether 
PWML or DWML are of more importance but this could depend on the definition of boundaries 
between the periventricular and deep WM if the coursing fibres are used as territory markers 
(Kovari et al. 2007).   Irrespective of these findings, there is still lack of robust data on whether 
WMH in different sub-regions e.g. PWML or DWML have differential effects on cognitive 
function.   
Diffusion tensor imaging (DTI) is currently widely used to investigate WM damage in 
the living brain (Croall et al. 2017, Gouw et al. 2008a).  DTI utilises measures of water diffusion 
to monitor microstructural alterations in WM tracts.  DTI parameters of fractional anisotropy and 
mean diffusivity provide more specific information on correlates of cognitive function than 
conventional MRI.   Thus, DTI shows progressive reduction in fractional anisotropy and 
increased mean diffusivity with increasing age, particularly in regions of interest within the 
centrum semiovale (Salat et al. 2005).  DTI parameters incorporating microstructural changes 
within the fibres are correlated with performance in cognitive domains associated with the 
frontal lobe including executive function, working memory and processing speed.  By use of 
lesion-symptom mapping data and information from probabilistic WM atlases, it appears that the 
anterior thalamic radiation is the major anatomical structure impacting on processing speed.  
These findings provide support for the role of frontal-subcortical circuits in cerebral SVD and 
vascular cognitive impairment (Duering et al. 2011, Kalaria & Ihara 2013, Benjamin et al. 
2014).   Furthermore, parallel studies using magnetic resonance spectroscopy suggest a positive 
correlation between the neuronal marker N-acetyl aspartate-creatine (NAA/Cr) and fractional 
anisotropy whereas a negative correlation with mean diffusivity.  These findings strengthen the 
evidence that DTI identifies axonal dysfunction or loss, or both along WM tracts in ageing and 
in cerebral SVD (Charlton et al. 2006, Nitkunan et al. 2006).   Consistent with the 
microstructural abnormalities, a recent meta-analysis showed that overall cerebral blood flow 
was low in regions which developed WMH (Shi et al. 2016).  
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Pathological substrates of WMH 
The cerebral WM comprises myelinated axons and various glial cells including myelinating 
oligodendrocytes, oligodendrocyte progenitor cells or NG2-glia, astrocytes and microglia (Table 
1).  These cellular structures embedded in the extracellular matrix are nourished by a network of 
capillaries extending from the perforating or medullary end arteries.  The pathological correlates 
of WMH comprise several patterns including myelin pallor or swelling, tissue rarefaction 
associated with loss of oligodendrocytes, diffuse axonal injury with thinning and varicosities, 
loosening of axon-oligodendrocyte adhesion and gliosis (Gouw et al. 2011, Deramecourt et al. 
2012, Skrobot et al. 2016, Hinman et al. 2015) (Figure 1).  The tissue changes include laucnes, 
microinfarcts, microbleeds and perivascular spacing accompanied by degrees of 
arteriolosclerosis.  Depending upon whether it is PWML or DWML, patterns of gliosis may be 
variable with macrophages present or absent around cavitations and perivascular regions of 
reactive astrogliosis (Simpson et al. 2007a).   Although few diffuse amyloid deposits may be 
evident, cerebral amyloid angiopathy or microatheromas are generally not evident in the WM 
(Kalaria et al. 2012).   Microarray studies have further demonstrated that compared to normal 
appearing WM, in DWML there was differential expression of key genes associated with the 
immune response, proteolysis, cell cycle progression and control, as well as ion transport 
(Simpson et al. 2009).  
As routine pathological sampling is likely to underestimate the burden of WML (Kalaria 
2016), some years ago we initiated identification of WML by post-mortem MRI (Fernando et 
al).  This technique was then adopted in the Cognitive Function in Ageing Study (CFAS) 
allowing MRI directed sampling for further histopathological assessment of lesional and normal 
appearing WM (Fernando et al. 2004).   Using this post-mortem approach, CFAS showed that 
WM pallor is related to dementia, independently of age and gender.   PWML are very common 
in ageing with 87% of non-demented and 95% of demented exhibiting variable degrees of 
changes (Matthews et al. 2009).  The odds ratios for dementia with severe PWML was 4.3 (95% 
CI 1.9–9.8) whereas DWML are seen in greater than 86% of those over 65 years.   DWMLs are 
also less common with 60% frequency in non-demented and 73% in demented individuals and 
the odds rations for dementia with severe DWML was 3.3 (1.6–6.8).   A combined diagnosis 
including both WML and histological evidence for SVD was greater in the demented group 
(32%) compared to non-demented group (24%) with an odds ratio for dementia of 2.9 (1.6–5.5) 
(Matthews et al. 2009).     
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Vascular pathology and related tissue ischaemic injury 
WM vascular changes are most prominent in VaD (Deramecourt et al. 2012).  However, all 
neurodegenerative dementias bear some degree of vascular pathology ranging from 61% in 
frontotemporal dementias to 82% in AD (Toledo et al. 2013).  Some of this pathology is 
invariably associated with the WM in the form of SVD.  Previous imaging and pathological 
studies indicated  that the medullary arteries and WM of the frontal lobe are especially 
susceptible to a haemodynamic derangement, leading to  much more severe WM damage, than 
for example in the temporal lobe, during ageing and vascular disease (Furuta et al. 1991, Ihara et 
al. 2010).   Age-related arteriosclerotic changes and segmental loss of vascular smooth muscle 
cells along lengths of both the medullary and perforating arteries disrupting flow in the distal 
arteries and affecting perfusion of the deep WM with the creation of an hypoxic environment 
(Fernando et al. 2006, Kalaria et al. 2015). 
In the CFAS (Matthews et al. 2009), WM vascular pathology as a gross measure was 
frequently observed with frequency of 71% in non-demented versus 84% in demented subjects.  
This was most frequently evident as SVD with 60% of elderly non-demented subjects exhibiting 
these features.  Both arteriolosclerosis and perivascular spacing were significantly greater in the 
DWML compared to normal appearing WM.  Quantitative assessment of vascular wall atrophy 
depicted by the sclerotic index reveals high values (>0.3) are characteristic of most ageing-
related dementias and SVD and particularly CADASIL (Fernando et al. 2006, Craggs et al. 
2013).   However, sclerotic indices of vessels within the frontal WM did not differentiate post-
stroke demented subjects from those who remained stable although there was increased sclerosis 
in VaD compared to AD subjects (Foster V and RNK, unpublished observations).  This was 
consistent with reductions in cerebral blood flow and cerebral perfusion in elderly stroke 
survivors who developed delayed dementia (Mori et al. 1994, Firbank et al. 2011).   It is 
plausible that perforating vessels are already affected as a consequence of ageing prior to 
induction of infarcts (Brown et al. 2009).   
The microvascular network within the WM though less dense is equally vulnerable as 
that in the neocortex.  The endothelium of capillaries is activated as indicated by increased 
expression of the intercellular adhesion molecule in relation to basement membrane collagen IV 
(Fernando et al. 2006).   The activation is often  accompanied by proliferation of microglia, 
which release proteases and free radicals to promote further damage over time to components on 
the extracellular matrix (Rosenberg 2017).  As in the cortex, basement membranes within 
arterioles and capillaries are thickened and undergo intimal thickening.  The microvascular 
network may also show severe distortions in terms of tortuosity, coiling and kinking with the 
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deep WM (Brown et al. 2009), which coincides with leukoariaosis.  Consistent with low tissue 
oxygen tension, within DWML there is induction of hypoxia-inducible factors 1alpha and 2alpha 
as well as key hypoxia-regulated proteins such as matrix metalloproteinase-7 and neuroglobin  
(Fernando et al. 2006).  These observations are consistent with elevated concentrations of the 
vasoconstrictor endothelin 1, reflecting abnormal regulation of WM perfusion (Barker et al. 
2014).  However, it is not clear at what threshold point diffuse WM damage implied by the 
microvascular changes tips over to impact on cognitive function. 
Lacunar infarcts (up to 15 mm in size) and microinfarcts are the most common types of 
vascular pathology related tissue changes in the WM with less frequency of microbleeds or 
hemosiderin accumulation (Figure 1).   In the recent CFAS, cortical microinfarcts were 
significantly related to higher deep WML scores whereas PWML were related to microinfarcts 
in subcortical regions (Ince et al. 2017).  Microbleeds or hemosiderin deposits on histological 
examination were evident in the WM but their incidence do not appear to be strongly associated 
with either the burden of WMH or SVD pathology (Janaway et al. 2014).  Lacunar infarcts are 
produced when ischaemic damage is focal and of sufficient severity to result in a small area of 
necrosis, whereas diffuse WM change is considered a form of rarefaction or incomplete 
infarction where there may be selective damage to several cellular components.  Recent imaging 
studies suggest the pathophysiology of lacunes and WMH is intimately linked and that more 
than 90% of lacunes evolve at the edge of WMH with a proximal predilection along the course 
of perforating vessels supplying the WM (Duering et al. 2013).  This association suggests that 
hypoperfused area or penumbral region at the edge of the degenerating WM is highly vulnerable 
to infarction.  Lacunes are independently associated with cognitive impairment with up to 37% 
incidence in elderly subjects (Makin et al. 2013, Jokinen et al. 2011).    
Previous imaging studies have indicated that the size of dilated PVS within the centrum 
semiovale was correlated with worsening cognitive function, particularly verbal memory 
(Maclullich et al. 2004).  Widened perivascular spaces in the WM increase with ageing and are a 
frequent occurrence in all dementias (Fernando et al. 2006, Kalaria 2016) (Figure 1).  It is likely 
that the increased burden and insufficiency in the drainage of the interstitial fluid (Pollock et al. 
1997) and degraded protein products (Weller et al. 2008, Jellinger 2007) into the lymphatic 
systems play a role in PVS enlargement within the WM. 
 
Myelin loss and cellular implications   
Plasma membranes of oligodendrocytes wrap around axons to form the protective myelin sheath 
(Emery 2010).  Myelin is tightly regulated by interplay between intrinsic oligodendrocytic and 
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extrinsic signals originating from astrocytes and non-glial WM cells and extracellular matrix 
components (Mitew et al. 2014, Itoh et al. 2011).   These signals determine oligodendrocyte 
precursor cell (OPC) differentiation to generate dense myelin around receptive axons.  Many of 
these regulatory mechanisms are essential for WM maintenance and repair (Fancy et al. 2011, 
van der Knaap & Bugiani 2017).  Of the four common myelin associated proteins namely 
myelin-associated glycoprotein (MAG), myelin basic protein (MBP), myelin oligodendrocyte 
glycoprotein and proteolipid protein (PLP), MAG is highly susceptible to ischemia, being 
expressed only adaxonally removed from the oligodendrocyte cell body.  MBP and PLP are 
expressed throughout the myelin sheath.    
Increased WM degeneration is evident by the greater accumulation of degenerating form 
of MBP (dMBP) (Ihara et al. 2010).  This is remarkably corroborated by decreased ratios of 
MBP and PLP which reflect ante-mortem WM ischemia and oligaemia or cerebral 
hypoperfusion in subjects with SVD and VaD compared to AD and ageing controls (Barker et 
al. 2013).  In the CFAS cohort, loss of myelin in both the DWML and PWML was evident.  
However,  the area of MBP loss in PWML was associated with a dense feltwork of 
subependymal glial fibrillary acidic protein (GFAP)-positive processes (Simpson et al. 2007a).   
PWML was also characterized by loss of ependymal cells, leaving gaps in the ependymal lining 
of the ventricle.  The breakdown of the ventricular lining may lead to back-diffusion of the 
cerebrospinal fluid and contribute to lesion pathogenesis in the periventricular caps (Figure 1).    
We previously showed that myelin density in the WM is most reduced in VaD compared 
to AD and other less prevalent dementias (Ihara et al. 2010, Sjobeck et al. 2005, Deramecourt et 
al. 2012).   However, quantitative analysis determined by myelin index scores suggests all 
dementias regardless of primary aetiology whether vascular or neurodegenerative show degrees 
of myelin loss compared to ageing controls (Figure 2).  Cognitively normal ageing controls also 
exhibit considerable myelin loss in relation to pathologically undamaged or intact WM with 
minimal vascular pathology.   Our bivariate analysis revealed that decreased myelin index 
(increased severity) in the frontal WM was strongly correlated with MMSE and CAMCOG 
scores, decreased executive function including attention and calculation (Foster V and RK, 
unpublished observations).  This is perhaps not surprising as loss of myelin may lead to 
disruption of one or more of cortico-subcortico pathways between the frontal cortex and the 
limbic system or those involving the anteromedial thalamic fibres (see above).  The loss of 
myelin would impact on not only the long-term structural integrity and viability of axons but 
also essential trophic support impairing the delivery of glycolysis products for mitochondria 
within the fibres (Nave & Werner 2014).   It is thought that rather than any direct toxic effect on 
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myelin, residing oligodendrocytes are likely vulnerable to the hypoxic environment within the 
lesional deep WM and impact on myelination (Nedergaard et al. 2003).   
 
Axonal Integrity 
Axonal pathology has been studied in several ageing-related disorders including AD (Adalbert & 
Coleman 2013) and SVD (Gouw et al. 2011, Hinman et al. 2015).  It was estimated that about 
half of the axons in the cerebral WM are myelinated and between age 20 and 80 years up to 45% 
of WM myelinated fibres are lost with thinner fibres being most affected (Marner et al. 2003).    
Axon density may further be affected by direct infarcts or by “dying back” processes (Adalbert 
& Coleman 2013).  To assess whether axons were similarly affected in regions of myelin loss, 
we estimated the density of axons in MRI defined lesional i.e. DWML compared to normal 
appearing WM.  Analysis using 3-dimensional stereological methods suggested that while 
estimated axon numbers  was replicated, surprisingly axonal density (expressed as length 
density)  in lesional areas (DWML) was not different to normal WM (Highley et al. 2014).  The 
relative axonal preservation in this context of myelin loss parallels with that of multiple 
sclerosis.  However, in CADASIL which is characterised as an aggressive cerebral SVD and 
exhibits severe WM pathology, SMI32 antibody immunoreactive axons signifying damage were 
invariably increased in tandem with 24-45% greater arteriolosclerosis (Craggs et al. 2014).    
The regional variability in degrees of axonal damage as revealed by SMI32 immunoreactivity 
suggests that early changes occur in the frontal lobe with a gradual WM disconnection involving 
the parietal and temporal lobes.  These observations also imply differential stenosis and sclerosis 
of arterioles in the WM lead to the widespread axonal abnormalities although the U fibres are 
generally spared.  The disruption of the cortico-cortical or cortico-subcortical networks in the 
WM of the frontal lobe may explain the motor deficits and executive dysfunction in severe SVD.   
 
Glial cells in the WM 
Besides myelin, abnormalities in axons, microvessels and glial cells particularly astrocytes and 
oligodendrocytes are of interest as possible substrates of WMH that correlate with cognitive 
impairment.   Different to rodents, the human WM contains abundant astrocytes which appear to 
be largely of the fibrous type as opposed to the protoplasmic type.  WM cell bodies of human 
astrocytes are larger and their processes are not aligned with myelinated fibres displaying an 
elongated morphology like in rodents (Lundgaard et al. 2014).   The key glial cell type of the 
WM is the oligodendrocyte, which originates as the oligodendrocyte precursor cell (OPC).  The 
proliferation and migration of OPCs appears to be controlled by astrocytes as they are the main 
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producers of the platelet-derived growth factor-alpha (PDGF) in the CNS (Richardson et al. 
1988).   Loss of astrocytic function could therefore impact on oligodendrocytes and contribute to 
WM integrity.   In addition, the WM is endowed with a host of microglia, macrophages and 
pericytes, which are all derived from the same lineage.  Ischaemic injury instigates differential 
responses during the temporal sequence and spatial distribution of these cells.   
 
Astrocytes   Astrocytes are one of the fundamental glial cells in the WM (Abbott et al. 2006).  
They are important in creating the appropriate milieu and providing energy for oligodendrocytes 
and axons (Funfschilling et al. 2012).   Astrocytes also contribute to maintenance of WM 
integrity and function by orchestrating the control of ion–water homeostasis and preventing 
intra-myelin oedema (Benfenati & Ferroni 2010).  Astrocytic end-feet processes cover more than 
90% of the microvasculature and play a crucial role in maintenance of the BBB in the WM.  The 
panglial syncytium, comprising a network of astrocytes, oligodendrocytes and ependymal cells 
interconnected by gap junctions disperses the water and ions (Depienne et al. 2013).   In vitro 
and in vivo studies show that astrocytes can also positively enhance myelination and 
remyelination.  Astrocytes of the WM exhibit regressive changes during ageing and apparently 
express markers of apoptosis (Kobayashi et al. 2002).  However, we found that the total 
astrocyte population in the frontal WM declined in tandem with increased astrocytic 
clasmatodendrosis in older age (Chen et al. 2016).  Experimental evidence from brain slices 
showed that astrocytic clasmatodendrosis occurs rather acutely initiated by acidosis (~pH 5) and 
energy failure induced by mitochondrial inhibition (Hulse et al. 2001).   The cellular changes are 
characterised by cytoplasmic swelling and vacuolation of the soma, with beading and 
fragmentation of the dendritic processes, leading to irreversible injury via an autophagy-like 
process (Qin et al. 2010).  These alterations in cell morphology are directly related to changes in 
cell function (Hulse et al. 2001, Hinson et al. 2007).   It is plausible that recurrent changes in 
perfusion pressure or chronic hypoperfusion may alter the local milieu to cause astrocytic 
clasmatodendrosis and disruption of gliovascular interactions, which progressively worsen with 
ageing.  
We previously noted markers of both myelin and axon damage including the myelin 
index and immunoreactivities of dMBP, amyloid precursor protein and SMI32 in the WM 
tended to be increased in post-stroke demented subjects (Foster et al. 2014, Akinyemi 2014).  
However, it was astrocytic clasmatodendrosis in the DWML remote from any infarction that 
separated the post-stroke demented from post-stroke stable subjects (Chen et al. 2016).  These 
observations are consistent the reduced distribution of metallothionein I/ II reactive astrocytes in 
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the subcortical layers of subjects with Binswanger’s disease (Zambenedetti et al. 2002) and 
regressive astroglial changes in the deep WM of a subject with Binswanger’s 
leukoencephalopathy and mixed dementia (AD combined with cerebrovascular disease) (Sahlas 
et al. 2002) although not necessarily associated with demyelination per se (Popescu et al. 2010).   
However, Tomimoto (Tomimoto et al. 1996, Tomimoto et al. 1997) had prior demonstrated that 
there were significantly more fibrinogen and immunoglobulins in brains exhibiting 
clasmatodendrosis than those without, which implicated dysfunction of the BBB (Kraig & 
Chesler 1990, Qin et al. 2010).  These observations collectively suggest that clasmatodendrosis 
is an important pathological gauge for disruption of gliovascular interactions with implications 
for the BBB (Abbott et al. 2006).    
 
Microglia  The WM predominantly contains ramified bipolar microglia and is devoid of large 
amoeboid microglia.  Microglia may be associated with several functions within the WM 
including surveillance at the BBB and clearance of myelin debris at sites of WM damage 
(Lampron et al. 2015, Skripuletz et al. 2013).   In earlier studies, using CD68 as a marker, we 
observed higher numbers of total microglia in WML, with higher levels in DWML and a trend to 
higher expression in PWML (Simpson et al. 2007b).   We further observed that although 
microglial activation i.e. cells with more retracted processes occurs in both PWML and DWML 
there were differences in their distribution.  PWML contained significantly more activated 
microglia, expressing major histocompatibility complex class II, the costimulatory molecules 
B7-2, CD40 and the replication licensing protein mini-chromosome maintenance protein 2.  This 
means the pathogenesis in the PWML contained the ramified, activated microglia reflects an 
immune activation likely resulting from disruption of the BBB as different from that in the 
DWML with opposed to the more innate, amoeboid phagocytic cells.  We observed that CD68 
positive activated amoeboid cells were increased in DWML in post-stroke demented subjects 
compared to non-demented survivors (YH et al, unpublished observations).  
Pericytes  Pericytes have multiple functions beyond contractile control of blood flow, providing 
paracrine signals during angiogenesis and phagocytic activity.  They are further specialised as a 
vital component of the BBB and their processes wrap around the length of capillaries to form 
close contacts with endothelial cells through peg and socket junctions, gap junctions and 
adhesion plaques (Hall et al. 2014).  PDGF-β expressed by endothelial cells recruits pericytes 
expressing PDGF receptor-β (PDGFR-β) to the capillary wall and inhibition of the signal results 
in fewer recruited pericytes to the vessel, causing vessel leakage, tortuosity, formation of 
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microaneurysms, and microbleeds (Carmeliet & Jain 2011).   While there is experimental 
evidence to suggest pericytes are impaired in ischaemic injury (Hall et al. 2014),  we have noted 
markedly decreased number of pericytes per capillary length in all dementias with marked loss 
in VaD (Ding et al. 2017).  In contrast, although there was evidence of fibrinogen leakage and 
reduced oxygenation of the underlying WM of the parietal cortex (precuneus), there was a lack 
of significant reduction in PDGFR-β reactivity used as a marker of pericytes in AD (Miners et 
al. 2017). 
 
Oligodendrocytes   In addition to myelination, remyelination and myelin maintenance, 
oligodendrocytes have vital roles in the metabolic support of axons.  Deficits in such support 
would impact on neurodegeneration (Bradl & Lassmann 2010).   WM oligodendrocytes decrease 
with ageing and express DNA damage markers such as 8-hydroxy deoxyguanosine (Al-
Mashhadi et al. 2015).   Our findings suggest that oligodendrocyte cell sizes are reduced in 
DWML likely caused by hypoperfusion or oligaemia.  The degenerative changes in 
oligodendrocytes appear to be a preliminary step towards cell death in the chronic hypoxic 
environment (Ihara et al. 2010).  Oligodendrocyte loss is compensated by differentiating OPCs, 
which increase during hypoxia/ischemia -induced injury, as an adaptive response for 
remyelination.  OPCs in the adult brain also contribute to WM homeostasis also by interacting 
with the endothelium and pericytes (Figure 3).  When the platelet-derived growth factor α 
receptor (PDGFR-α) and the +13 isoform of microtubule-associated protein-2 (MAP-2+13) were 
used as markers, some of the oligodendroglial cells showed a T-shaped pattern of cytoplasmic 
labelling for MAP-2+13.  These cells assuming the morphology of pre-myelinating 
oligodendrocytes were more frequent in the PWML than in the DWML, particularly at lesion 
margins. These findings suggested that there may be some attempt by OPCs to remyelinate 
although greater repair mechanisms may be impaired by age and by degree of pathology 
(Boulanger & Messier 2014).     The paucity of OPCs in DWML may also relate to the hypoxic 
environment within the deep WM with selective effects on oligodendroglial lineage components.   
Consistent with this notion, remyelinating oligodendrocytes were reported to be lost in the centre 
of severely demyelinated WM but proliferated in the perilesional WM (Simpson et al. 2007a). 
  
Gliovascular Interactions and the Blood- Brain Barrier in WM   
The concept of the gliovascular unit in the WM is in keeping with the model of the 
neurovascular unit in the grey matter (Figure 3).  The principal components of the gliovascular 
unit comprising astrocytes juxtaposed to microvessels largely in form of capillaries play a 
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prominent role in maintaining homeostasis of the BBB.  Disturbances in cells forming this unit 
may critically dysregulate exchange between the blood and the WM tissue.  The unit, however, 
also incorporates pericytes with links to OPCs and microglia (Maki et al. 2015a).   There is 
similarly an oligovascular niche, which entails interactions between oligodendrocytes and 
endothelial cells (Rajani & Williams 2017).    
Tight junction proteins such as claudin-V and zona-occludin-1 form tight junction 
complexes which contribute to the integrity of the BBB (Simpson et al. 2010).  Abnormalities in 
these proteins have been observed in a number of disorders associated with BBB dysfunction 
(Sandoval & Witt 2008, Weiss et al. 2009).  Quantification of these proteins to assess disruption 
of tight junctions and use as surrogate markers of BBB permeability indicated that these were 
not significantly affected in MRI defined DWML although there was widespread albumin 
extravasation (Simpson et al. 2010, Goodall et al. 2017).   In contrast, loss of astrocytes and 
retraction of the end-feet which express the transmembrane protein aquaporin 4 (AQP4) that 
forms channels selective for water mobility (Nagelhus & Ottersen 2013) was severely affected in 
the DWML (Chen et al. 2016).  The anchoring of AQP4 from the cytoplasm of astrocytes to the 
extracellular matrix is dependent on the dystrophin-associated protein complex.  Dystrophin 
connects the filamentous actin in the cytoskeleton to β-dystroglycan, which in turn is bound by 
laminin and agrin of the basement membranes (Nagelhus & Ottersen 2013).  Since capillary 
basement membranes, the key elements for fluid drainage from the parenchyma are secreted by 
astrocyte end-feet, the loss of AQP4 would also impair the integrity of basement membranes 
(Carare et al. 2008, Yao et al. 2014).   Altered AQP4 distribution in the retracted processes and 
the swelling of astrocytic cell bodies thus impacts on water mobility or water homeostasis and 
the local microcirculation (Taniguchi et al. 2000, Badaut et al. 2002).   
 
Contribution of laboratory animal studies  
Several animal models have been developed to gain mechanistic insights into the 
pathophysiology of the WM matter and enable translation to the clinic (Duncombe et al. 2017). 
While efficient models to examine the sequelae of global and focal ischaemic injury have been 
useful, they have been limited to fully explore various features of WM changes in the context of 
cerebral hypoperfusion and cerebral SVD.  To simulate specific aspects of WM changes 
resulting from reduced perfusion of the WM, we have focussed on models of bilateral common 
carotid artery occlusion in rats (referred to as two-vessel occlusion), bilateral common carotid 
artery stenosis (BCAS) in mice and recently developed bilateral common carotid artery gradual 
occlusion in rats and mice (Nishio et al. 2010, Kitamura et al. 2012, Hattori et al. 2016b).   
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The original BCAS experimental model (Shibata et al. 2004) established in mice is most 
relevant to produce cerebral hypoperfusion (Tomimoto et al. 2003) by reducing blood flow in 
both cortical and subcortical structures over a sustained period (Hattori et al. 2016a).  The BCAS 
model shares several pathological consequences with cerebral SVD including microinfarcts, 
microhaemorrhages and WM disruption (Holland et al. 2015, Hase et al. 2017).   BCAS causes 
gliovascular changes with marked increases in microvessel diameter, vascular wall disruption, 
and fibrinoid necrosis, microhaemorrhages, and BBB alterations.   The GCAS model (Hattori et 
al. 2016b) similarly induces gradual and continuous reduction of cerebral blood flow with 
replication of several histological, radiological, and behavioural features associated with cerebral 
hypoperfusion leading to vascular cognitive impairment.   
We previously showed that BCAS impaired cognitive function as indicated by longer 
latencies in the radial arm maze paradigm, impairing nesting ability and causing greater anxiety 
behaviour.   The radial arm maze latencies in older mice (21 months) with BCAS were longer 
compared to those in younger (3 month) mice indicating greater impairment of hippocampal 
dependent learning and working memory (Wolf et al. 2017).   However, at 4 months after BCAS 
surgery, WM disintegration is quite severe as evident by atrophy along the whole length of the 
corpus callosum.  Consistent with this, MBP was much reduced in the 21 month old mice that 
may already be compromised by ageing (Wolf et al. 2017).   Chronic cerebral hypoperfusion 
leads to a rapid disruption of key proteins critical to the stability of the axon-glial connection, 
which is mediated by a diversity of molecular events (Reimer et al. 2011).  As early as 3 days, 
hypoperfusion damages the paranodal septate-like junctions of myelinated axons.  With 
continued hypoperfusion there is progressive reduction of the paranodal Neurofascin signal and 
loss of septate-like junctions.  Concurrent with paranodal disruption, the nodal length is 
increased with changes in the spatial distribution of MAG.   The APP23 mice show a 
progressive loss of myelin associated glycoprotein and NF186 from 6 to 12 months, disordered 
distribution of myelin basic protein, and extended relocation of the channel proteins Nav1.6 and 
AnkG beyond the primary nodal region in the corpus callosum.   These observations suggest 
WM integrity is compromised along axons at intermodal, paranodal, and Ranvier's nodal sites.  
These changes  can be protected by galantamine treatment (Zhai et al. 2016).      
Ageing exacerbates the effects to induce more severe WM degeneration and cognitive 
phenotypes.  Thus, consequences of cerebral hypoperfusion including myelin loss, severe loss of 
oligodendrocytes, activation of inflammatory processes and cognitive impairment were more 
severe in aged mice (Duncombe et al. 2016, Wolf et al. 2017).   While there could be an attempt 
for myelin replacement as suggested by increased number of immunolabelled NG2 cells even in  
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old BCAS mice (Wolf et al. 2017),  these changes including the preservation of 
oligodendrocytes can be attenuated by environmental enrichment (EE) intervention more so by 
limited (3 hours per day) rather than full-time exposure to EE (Hase et al. 2017).  Moderate level 
of EE or physical activity appears more beneficial in sustaining WM integrity than no 
enrichment after chronic hypoperfusion.  One of the targets which is critical for the protection of 
the WM is the cerebral endothelium (Trigiani & Hamel 2017).  However, WM integrity in the 
aged mouse is vulnerable to prolonged cerebral hypoperfusion and hypoxic stress, and loses its 
ability to also recruit cyclic AMP response element-binding protein (CREB)-mediated 
oligodendrogenesis for responding to WM injury and stress (Miyamoto et al. 2013b).   
Assessment of CREB-mediated oligodendrogenesis in the WM could be one mechanism to 
elucidate the effects of limited exposure to EE against WM damage.   
BCAS induced WM damage evolves in parallel with bone marrow protein 4 (BMP4) 
upregulation in pericytes, promoting angiogenesis but inducing astrogliogenesis at the expense 
of OPC proliferation and maturation (Uemura et al. 2017).  Since this aggravates WM damage 
subsequent to chronic hypoperfusion the regulation of BMP4 signalling is a potential therapeutic 
strategy for treating WM degeneration (Uemura et al. 2017).   The recent identification of a 
novel pathway in which astrocyte-derived brain derived nerve growth factor supports 
oligodendrogenesis (Miyamoto et al. 2015) is yet another approach for the amelioration of WM 
integrity by promoting OPCs, which may serve as a reserve for generating mature 
oligodendrocytes in damaged WM.  In perivascular regions of cerebral WM, pericytes  may 
interact functionally with OPCs to support each other given that pericyte numbers increased 
when they were maintained in OPC-conditioned media (Maki et al. 2015a).  However, prior to 
myelin loss OPCs rapidly responded to WM changes by producing metallomatrix protein 
(MMP)-9 to cause BBB leakage and neutrophil infiltration, indicating that OPCs mediate early 
injury in WM under disease conditions (Seo et al. 2013).   
Long-term BCAS induces thickening of carotid artery walls and consequent prolonged 
reduction in cerebral blood flow (Hase et al. 2016).  Compensation through collateral flow is not 
able to prevent reduction in cerebral blood flow but the reduction in flow likely instigates 
damage in the deep WM particularly targeting oligodendrocytes (Shibata et al. 2004, Nishio et 
al. 2010, Washida et al. 2010, Maki et al. 2011b).   Cerebral hypoperfusion therefore also 
contributes to disconnectivity between cerebral cortices and subcortical structures that result in 
cognitive and motor deficits (Yamauchi et al. 2000, Jokinen et al. 2007, Ryberg et al. 2011, 
Ihara et al. 2010).   
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Consistent with the increased degeneration of astrocytes in the deep WM (Chen et al. 
2016, Tomimoto et al. 1997) , typical clasmatodendrosis  identified by damaged fibrous 
astrocytes with enlarged cell bodies and loss of processes is also evident in BCAS mice.  The 
percentage of clasmatodendrocytes per all GFAP-positive astrocytes was negatively correlated 
with WM volumes.  This was accompanied by profound disruption of AQP4 immunoreactivity 
(Figure 4) and increased degrees of microglial activation/proliferation.   Interestingly, long-term 
treatment with the pleotropic compound cilostazol, which is a phosphodiesterase III inhibitor 
and an antiplatelet agent, ameliorated gliovascular damage and working memory impairments 
after BCAS possibly acting by protecting the endothelium (Kitamura et al. 2017).   Preventing 
chronic cerebral hypoperfusion therefore ought to reduce BBB disruption and maintain the 
gliovascular integrity.   
The astrocytic end-feet AQP4 dislocation caused by BCAS presumably enhances WM 
pathology due to a disturbance in water homeostasis (Figure 4).  These studies suggest that 
BCAS instigates flow changes and pathological alterations in small arteries and capillaries of the 
WM leading to breach of the BBB (Mueller 1982, Tang et al. 1993, Tomimoto et al. 1996).   
Such spatial dissociation between the vascular basement membrane and the astrocyte end-feet 
also occurs in brains of spontaneously hypertensive rats with middle cerebral artery occlusion 
(MCAO) (Yamashita et al. 2009).  The basement membrane/extracellular matrix linking 
endothelial cells are key in maintaining the integrity of the neuro- or gliovascular units, which 
can be disrupted by tissue plasminogen activator treatment.  Microglia in older BCAS mice 
exhibited striking activation in the area of degraded myelin compared to young adult or old 
control mice (Wolf et al. 2017).   Minocycline, a proposed anti-inflammatory and microglia 
inhibitor, restored WM function related to a reduction in the number of microglia associated 
with alterations in myelinated axons induced by cerebral hypoperfusion (Manso et al. 2017). 
Given the different cellular alterations occurring in the hypoperfused WM, several 
translational approaches have been attempted.  Reactive astrocytes express activated p38 
mitogen activated protein kinases (p38 MAPK) and pro-inflammatory transcription factor 
nuclear factor (NF)-kB (Saggu et al. 2016) besides producing reactive oxygen species (ROS) 
(Nahirnyj et al. 2013) and reinforcing cellular inflammation (Cuadrado & Nebreda 2010). 
Therefore, targeting astrocytes with agents that return them to a quiescent phenotype 
(Choudhury & Ding 2016) could be protective for the WM.  Similarly, identifying molecular 
targets (Wang et al. 2013) of microglial activation and microglial suppressant agents similar to 
minocycline (Cai et al. 2006, Ma et al. 2015), ethyl pyruvate (Shen et al. 2010), edaravone 
(Miyamoto et al. 2014, Miyamoto et al. 2013a)  and autophagy inhibitors such as (3-
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methyladenine) could attenuate microglial activation (Yang et al. 2014)  and protect against the 
WM from further damage.  The overproduction of ROS, pro-inflammatory cytokines and matrix 
metalloproteinases (e. g. MMP-2, MMP-9) (Ihara et al. 2001, Miyamoto et al. 2014) by 
microglia or other glial cells promotes BBB disruption and glial activation (Nakaji et al. 2006, 
Wake et al. 2009).   
Other approaches such as aliskiren, a direct renin inhibitor, or Tempol, a superoxide 
scavenger may also target oxidative stress to reduce WM damage (Dong et al. 2011).   
Telmisartan, an angiotensin II Type 1 receptor blocker with anti-inflammatory and antioxidative 
effects was protective against WM damage (Washida et al. 2010).   WM damage is exacerbated 
by adrenomedullin deficiency, which induces oxidative stress and hyperglycemia.  Thus 
adrenomedullin is another potentially important target in the control of ischemic WM injury 
(Mitome-Mishima et al. 2014).  Adrenomedullin was shown to also promote arteriogenesis and 
angiogenesis, inhibit oxidative stress and attenuate WM damage (Maki et al. 2011b, Maki et al. 
2011a).  In addition, it promoted  regeneration of oligodendrocytes subsequent to WM changes 
(Maki et al. 2015b). 
 
Summary and Perspectives  
WM degeneration is common in ageing and ageing-related dementias.   It is clear that high 
burden of WML is associated with cognitive decline and dementia.  WML have been 
conveniently demarcated as PWML and DWML.  Post-mortem imaging and neuropathological 
studies suggest different aetiologies are associated with periventricular and deep WM changes.  
However, PWML and DWML need to be better evaluated in terms of loss of specific functions.  
Multiple substrates including arteriolosclerosis, myelin loss and gliosis within the degenerating 
WM collectively appear to contribute to cognitive impairment.   The integrity of the gliovascular 
unit instigated by astrocytic clasmatodendrosis is paramount to maintenance of the BBB and 
WM physiological function.  Besides astrocytes, interactions between other cellular components 
of the gliovascular unit need to be carefully evaluated.  The roles of microglia, perivascular 
macrophages and pericytes also need to be better defined.  Animal models of cerebral 
hypoperfusion where the WM has been the focus have provided several insights into the 
pathophysiology and some novel cellular interactions including the oligovascular niche.  Animal 
models have enabled testing of different agents targeting detrimental processes such as oxidative 
stress and inflammation.  While many of these are reasonably efficacious further refinements are 
needed to identify the most effective strategy for the protection of the WM.   
 
Hase Y et al , J Neurochem, submitted 
 
20 
 
 
Acknowledgements 
We are grateful to the patients, families, and clinical house staff for supporting our longitudinal 
studies.   We are also grateful to Vincent Foster for allowing us to report some of the results 
from his PhD Thesis. 
 
Funding 
Our work is supported by grants from the Dunhill Medical Trust (UK),  Medical Research 
Council (MRC, G0500247), Newcastle Centre for Brain Ageing and Vitality (BBSRC, EPSRC, 
ESRC and MRC, LLHW), and Alzheimer’s Research (ARUK).  Our work is also supported by 
the Newcastle Brain Tissue Resource, which is funded in part by a grant from the UK MRC 
(G0400074), by the Newcastle NIHR Biomedical Research Centre in Ageing and Age Related 
Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation Trust, and by a grant 
from the Alzheimer’s Society and ARUK as part of the Brains for Dementia Research Project.   
 
Author contribution 
Yoshiki Hase generated the original data and corrected several drafts of the review. 
Karen Horsburgh provided intellectual input and corrected drafts of the review. 
Masafumi Ihara conceived some aspects of review and corrected drafts of the review. 
Raj N. Kalaria conceived the review, wrote the original manuscript and corrected several drafts 
and obtained the funding. 
 
Conflict of interest 
The co-authors have no disclosures with regard to this report.  There are no conflicts of interest. 
  
Hase Y et al , J Neurochem, submitted 
 
21 
 
References 
Abbott, N. J., Ronnback, L. and Hansson, E. (2006) Astrocyte-endothelial interactions at the 
blood-brain barrier. Nature reviews. Neuroscience, 7, 41-53. 
Adalbert, R. and Coleman, M. P. (2013) Review: Axon pathology in age-related 
neurodegenerative disorders. Neuropathology and applied neurobiology, 39, 90-108. 
Adib-Samii, P., Devan, W., Traylor, M. et al. (2015) Genetic architecture of white matter 
hyperintensities differs in hypertensive and nonhypertensive ischemic stroke. Stroke; a 
journal of cerebral circulation, 46, 348-353. 
Adib-Samii, P., Rost, N., Traylor, M. et al. (2013) 17q25 Locus is associated with white matter 
hyperintensity volume in ischemic stroke, but not with lacunar stroke status. Stroke; a 
journal of cerebral circulation, 44, 1609-1615. 
Akinyemi, R. O. (2014) Profile, determinants and mechanisms of cerebral injury and cognitive 
impairment following stroke. In: Institute of Neuroscience, Vol. PhD Thesis, pp. 280. 
Newcastle University, Newcastle upon Tyne. 
Al-Mashhadi, S., Simpson, J. E., Heath, P. R. et al. (2015) Oxidative Glial Cell Damage 
Associated with White Matter Lesions in the Aging Human Brain. Brain pathology, 25, 
565-574. 
Appelman, A. P., Exalto, L. G., van der Graaf, Y., Biessels, G. J., Mali, W. P. and Geerlings, M. 
I. (2009) White matter lesions and brain atrophy: more than shared risk factors? A 
systematic review. Cerebrovascular diseases, 28, 227-242. 
Atwood, L. D., Wolf, P. A., Heard-Costa, N. L., Massaro, J. M., Beiser, A., D'Agostino, R. B. 
and DeCarli, C. (2004) Genetic variation in white matter hyperintensity volume in the 
Framingham Study. Stroke; a journal of cerebral circulation, 35, 1609-1613. 
Badaut, J., Lasbennes, F., Magistretti, P. J. and Regli, L. (2002) Aquaporins in brain: 
distribution, physiology, and pathophysiology. Journal of cerebral blood flow and 
metabolism : official journal of the International Society of Cerebral Blood Flow and 
Metabolism, 22, 367-378. 
Baradaran, H., Mtui, E. E., Richardson, J. E., Delgado, D., Dunning, A., Marshall, R. S., Sanelli, 
P. C. and Gupta, A. (2016) White Matter Diffusion Abnormalities in Carotid Artery 
Disease: A Systematic Review and Meta-Analysis. Journal of neuroimaging : official 
journal of the American Society of Neuroimaging. 
Barker, R., Ashby, E. L., Wellington, D., Barrow, V. M., Palmer, J. C., Kehoe, P. G., Esiri, M. 
M. and Love, S. (2014) Pathophysiology of white matter perfusion in Alzheimer's disease 
and vascular dementia. Brain : a journal of neurology, 137, 1524-1532. 
Hase Y et al , J Neurochem, submitted 
 
22 
 
Barker, R., Wellington, D., Esiri, M. M. and Love, S. (2013) Assessing white matter ischemic 
damage in dementia patients by measurement of myelin proteins. Journal of cerebral 
blood flow and metabolism : official journal of the International Society of Cerebral Blood 
Flow and Metabolism, 33, 1050-1057. 
Benfenati, V. and Ferroni, S. (2010) Water transport between CNS compartments: functional 
and molecular interactions between aquaporins and ion channels. Neuroscience, 168, 926-
940. 
Benjamin, P., Lawrence, A. J., Lambert, C., Patel, B., Chung, A. W., MacKinnon, A. D., Morris, 
R. G., Barrick, T. R. and Markus, H. S. (2014) Strategic lacunes and their relationship to 
cognitive impairment in cerebral small vessel disease. NeuroImage. Clinical, 4, 828-837. 
Bolandzadeh, N., Davis, J. C., Tam, R., Handy, T. C. and Liu-Ambrose, T. (2012) The 
association between cognitive function and white matter lesion location in older adults: a 
systematic review. BMC Neurol, 12, 126. 
Boulanger, J. J. and Messier, C. (2014) From precursors to myelinating oligodendrocytes: 
contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain. 
Neuroscience, 269, 343-366. 
Bradl, M. and Lassmann, H. (2010) Oligodendrocytes: biology and pathology. Acta 
neuropathologica, 119, 37-53. 
Brown, W. R., Moody, D. M., Thore, C. R., Anstrom, J. A. and Challa, V. R. (2009) 
Microvascular changes in the white matter in dementia. Journal of the neurological 
sciences, 283, 28-31. 
Burton, E. J., Kenny, R. A., O'Brien, J. et al. (2004) White matter hyperintensities are associated 
with impairment of memory, attention, and global cognitive performance in older stroke 
patients. Stroke; a journal of cerebral circulation, 35, 1270-1275. 
Cai, Z., Lin, S., Fan, L. W., Pang, Y. and Rhodes, P. G. (2006) Minocycline alleviates hypoxic-
ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience, 
137, 425-435. 
Carare, R. O., Bernardes-Silva, M., Newman, T. A., Page, A. M., Nicoll, J. A., Perry, V. H. and 
Weller, R. O. (2008) Solutes, but not cells, drain from the brain parenchyma along 
basement membranes of capillaries and arteries: significance for cerebral amyloid 
angiopathy and neuroimmunology. Neuropathology and applied neurobiology, 34, 131-
144. 
Carmeliet, P. and Jain, R. K. (2011) Molecular mechanisms and clinical applications of 
angiogenesis. Nature, 473, 298-307. 
Hase Y et al , J Neurochem, submitted 
 
23 
 
Charlton, R. A., Barrick, T. R., McIntyre, D. J., Shen, Y., O'Sullivan, M., Howe, F. A., Clark, C. 
A., Morris, R. G. and Markus, H. S. (2006) White matter damage on diffusion tensor 
imaging correlates with age-related cognitive decline. Neurology, 66, 217-222. 
Chen, A., Akinyemi, R. O., Hase, Y. et al. (2016) Frontal white matter hyperintensities, 
clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. 
Brain : a journal of neurology, 139, 242-258. 
Choudhury, G. R. and Ding, S. (2016) Reactive astrocytes and therapeutic potential in focal 
ischemic stroke. Neurobiology of disease, 85, 234-244. 
Craggs, L. J., Hagel, C., Kuhlenbaeumer, G. et al. (2013) Quantitative vascular pathology and 
phenotyping familial and sporadic cerebral small vessel diseases. Brain pathology, 23, 
547-557. 
Craggs, L. J., Yamamoto, Y., Ihara, M. et al. (2014) White matter pathology and disconnection 
in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL). Neuropathology and applied neurobiology, 40, 
591-602. 
Croall, I. D., Lohner, V., Moynihan, B. et al. (2017) Using DTI to assess white matter 
microstructure in cerebral small vessel disease (SVD) in multicentre studies. Clinical 
science, 131, 1361-1373. 
Cuadrado, A. and Nebreda, A. R. (2010) Mechanisms and functions of p38 MAPK signalling. 
The Biochemical journal, 429, 403-417. 
de Leeuw, F. E., de Groot, J. C., Achten, E. et al. (2001) Prevalence of cerebral white matter 
lesions in elderly people: a population based magnetic resonance imaging study. The 
Rotterdam Scan Study. Journal of neurology, neurosurgery, and psychiatry, 70, 9-14. 
Debette, S. and Markus, H. S. (2010) The clinical importance of white matter hyperintensities on 
brain magnetic resonance imaging: systematic review and meta-analysis. Bmj, 341, c3666. 
Depienne, C., Bugiani, M., Dupuits, C. et al. (2013) Brain white matter oedema due to ClC-2 
chloride channel deficiency: an observational analytical study. The Lancet. Neurology, 12, 
659-668. 
Deramecourt, V., Slade, J. Y., Oakley, A. E., Perry, R. H., Ince, P. G., Maurage, C. A. and 
Kalaria, R. N. (2012) Staging and natural history of cerebrovascular pathology in 
dementia. Neurology, 78, 1043-1050. 
Ding, R., Barsby, J., Slade, J. Y., Oakley, A. E. and Kalaria, R. (2017) The role of cerebral 
pericytes in the frontal white matter of ageing related dementias. Alzheimers & Dementia, 
in press  
Hase Y et al , J Neurochem, submitted 
 
24 
 
Dong, Y. F., Kataoka, K., Toyama, K. et al. (2011) Attenuation of brain damage and cognitive 
impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. 
Hypertension, 58, 635-642. 
Duering, M., Csanadi, E., Gesierich, B. et al. (2013) Incident lacunes preferentially localize to 
the edge of white matter hyperintensities: insights into the pathophysiology of cerebral 
small vessel disease. Brain : a journal of neurology, 136, 2717-2726. 
Duering, M., Gesierich, B., Seiler, S. et al. (2014) Strategic white matter tracts for processing 
speed deficits in age-related small vessel disease. Neurology, 82, 1946-1950. 
Duering, M., Righart, R., Csanadi, E., Jouvent, E., Herve, D., Chabriat, H. and Dichgans, M. 
(2012) Incident subcortical infarcts induce focal thinning in connected cortical regions. 
Neurology, 79, 2025-2028. 
Duering, M., Zieren, N., Herve, D. et al. (2011) Strategic role of frontal white matter tracts in 
vascular cognitive impairment: a voxel-based lesion-symptom mapping study in 
CADASIL. Brain : a journal of neurology, 134, 2366-2375. 
Duncombe, J., Kitamura, A., Hase, Y., Ihara, M., Kalaria, R. and Horsburgh, K. (2017) Chronic 
cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and 
dementia (VCID): Closing the translational gap between rodent models and human VCID. 
Clinical science, In press. 
Duncombe, J., Lennen, R. J., Jansen, M. A., Marshall, I., Wardlaw, J. M. and Horsburgh, K. 
(2016) Ageing causes prominent neurovascular dysfunction associated with loss of 
astrocytic contacts and gliosis. Neuropathology and applied neurobiology. 
Emery, B. (2010) Regulation of oligodendrocyte differentiation and myelination. Science, 330, 
779-782. 
Fancy, S. P., Chan, J. R., Baranzini, S. E., Franklin, R. J. and Rowitch, D. H. (2011) Myelin 
regeneration: a recapitulation of development? Annual review of neuroscience, 34, 21-43. 
Fazekas, F., Kleinert, R., Offenbacher, H., Payer, F., Schmidt, R., Kleinert, G., Radner, H. and 
Lechner, H. (1991) The morphologic correlate of incidental punctate white matter 
hyperintensities on MR images. AJNR. American journal of neuroradiology, 12, 915-921. 
Fernando, M. S., O'Brien, J. T., Perry, R. H. et al. (2004) Comparison of the pathology of 
cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly 
brain. Neuropathology and applied neurobiology, 30, 385-395. 
Fernando, M. S., Simpson, J. E., Matthews, F. et al. (2006) White matter lesions in an unselected 
cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion 
injury. Stroke; a journal of cerebral circulation, 37, 1391-1398. 
Hase Y et al , J Neurochem, submitted 
 
25 
 
Firbank, M. J., He, J., Blamire, A. M., Singh, B., Danson, P., Kalaria, R. N. and O'Brien, J. T. 
(2011) Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology, 76, 
1478-1484. 
Fornage, M., Debette, S., Bis, J. C. et al. (2011) Genome-wide association studies of cerebral 
white matter lesion burden: the CHARGE consortium. Annals of neurology, 69, 928-939. 
Foster, V., Oakley, A. E., Slade, J. Y. et al. (2014) Pyramidal neurons of the prefrontal cortex in 
post-stroke, vascular and other ageing-related dementias. Brain : a journal of neurology. 
Frings, L., Yew, B., Flanagan, E., Lam, B. Y., Hull, M., Huppertz, H. J., Hodges, J. R. and 
Hornberger, M. (2014) Longitudinal grey and white matter changes in frontotemporal 
dementia and Alzheimer's disease. PloS one, 9, e90814. 
Funfschilling, U., Supplie, L. M., Mahad, D. et al. (2012) Glycolytic oligodendrocytes maintain 
myelin and long-term axonal integrity. Nature, 485, 517-521. 
Furuta, A., Ishii, N., Nishihara, Y. and Horie, A. (1991) Medullary arteries in aging and 
dementia. Stroke; a journal of cerebral circulation, 22, 442-446. 
Goodall, E. F., Wang, C., Simpson, J. E., Baker, D. J., Drew, D. R., Heath, P. R., Saffrey, M. J., 
Romero, I. A. and Wharton, S. B. (2017) Age-associated changes in the blood-brain 
barrier: comparative studies in human and mouse. Neuropathology and applied 
neurobiology. 
Gouw, A. A., Seewann, A., van der Flier, W. M., Barkhof, F., Rozemuller, A. M., Scheltens, P. 
and Geurts, J. J. (2011) Heterogeneity of small vessel disease: a systematic review of MRI 
and histopathology correlations. Journal of neurology, neurosurgery, and psychiatry, 82, 
126-135. 
Gouw, A. A., Seewann, A., Vrenken, H., van der Flier, W. M., Rozemuller, J. M., Barkhof, F., 
Scheltens, P. and Geurts, J. J. (2008a) Heterogeneity of white matter hyperintensities in 
Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain : a journal 
of neurology, 131, 3286-3298. 
Gouw, A. A., van der Flier, W. M., Fazekas, F. et al. (2008b) Progression of white matter 
hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and 
Disability study. Stroke; a journal of cerebral circulation, 39, 1414-1420. 
Hachinski, V. C., Potter, P. and Merskey, H. (1987) Leuko-araiosis. Archives of neurology, 44, 
21-23. 
Hainsworth, A. H., Minett, T., Andoh, J. et al. (2017) Neuropathology of White Matter Lesions, 
Blood-Brain Barrier Dysfunction, and Dementia. Stroke; a journal of cerebral circulation, 
48, 2799-2804. 
Hase Y et al , J Neurochem, submitted 
 
26 
 
Hall, C. N., Reynell, C., Gesslein, B. et al. (2014) Capillary pericytes regulate cerebral blood 
flow in health and disease. Nature, 508, 55-60. 
Hase, Y., Craggs, L., Hase, M. et al. (2017) The effects of environmental enrichment on white 
matter pathology in a mouse model of chronic cerebral hypoperfusion. Journal of cerebral 
blood flow and metabolism : official journal of the International Society of Cerebral Blood 
Flow and Metabolism, 271678X17694904. 
Hase, Y., Craggs, L., Stevenson, W., Hase, M., Slade, J. Y., Oakley, A. E., Ihara, M., Horsburgh, 
K. and Kalaria, R. N. (2016) Effects of Environmental Enrichment/Physical Exercise on 
White Matter Integrity and Stroke injury in a Mouse Model of Chronic Cerebral 
Hypoperfusion. Cerebrovascular diseases, 41, Suppl 1, 199. 
Hattori, Y., Enmi, J., Iguchi, S., Saito, S., Yamamoto, Y., Nagatsuka, K., Iida, H. and Ihara, M. 
(2016a) Substantial Reduction of Parenchymal Cerebral Blood Flow in Mice with Bilateral 
Common Carotid Artery Stenosis. Scientific reports, 6, 32179. 
Hattori, Y., Enmi, J., Iguchi, S. et al. (2016b) Gradual Carotid Artery Stenosis in Mice Closely 
Replicates Hypoperfusive Vascular Dementia in Humans. Journal of the American Heart 
Association, 5. 
Highley, J. R., Gebril, O. H., Simpson, J. E. et al. (2014) Axonal Preservation in Deep 
Subcortical White Matter Lesions in the Ageing Brain. Aging Sci, 2, 118-119. 
Hinman, J. D., Lee, M. D., Tung, S., Vinters, H. V. and Carmichael, S. T. (2015) Molecular 
disorganization of axons adjacent to human lacunar infarcts. Brain : a journal of 
neurology, 138, 736-745. 
Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J. and 
Lennon, V. A. (2007) Pathogenic potential of IgG binding to water channel extracellular 
domain in neuromyelitis optica. Neurology, 69, 2221-2231. 
Holland, P. R., Searcy, J. L., Salvadores, N. et al. (2015) Gliovascular disruption and cognitive 
deficits in a mouse model with features of small vessel disease. Journal of cerebral blood 
flow and metabolism : official journal of the International Society of Cerebral Blood Flow 
and Metabolism, Feb 11. doi: 10.1038/jcbfm.2015.12. 
Hulse, R. E., Winterfield, J., Kunkler, P. E. and Kraig, R. P. (2001) Astrocytic 
clasmatodendrosis in hippocampal organ culture. Glia, 33, 169-179. 
Ihara, M., Polvikoski, T. M., Hall, R. et al. (2010) Quantification of myelin loss in frontal lobe 
white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. 
Acta neuropathologica, 119, 579-589. 
Hase Y et al , J Neurochem, submitted 
 
27 
 
Ihara, M., Tomimoto, H., Kinoshita, M., Oh, J., Noda, M., Wakita, H., Akiguchi, I. and 
Shibasaki, H. (2001) Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 
expression in the microglia and vascular endothelium of white matter. Journal of cerebral 
blood flow and metabolism : official journal of the International Society of Cerebral Blood 
Flow and Metabolism, 21, 828-834. 
Ince, P. G., Minett, T., Forster, G., Brayne, C., Wharton, S. B., Medical Research Council 
Cognitive, F. and Ageing Neuropathology, S. (2017) Microinfarcts in an older population-
representative brain donor cohort (MRC CFAS): Prevalence, relation to dementia and 
mobility, and implications for the evaluation of cerebral Small Vessel Disease. 
Neuropathology and applied neurobiology, 43, 409-418. 
Inzitari, D., Pracucci, G., Poggesi, A. et al. (2009) Changes in white matter as determinant of 
global functional decline in older independent outpatients: three year follow-up of LADIS 
(leukoaraiosis and disability) study cohort. Bmj, 339, b2477. 
Itoh, Y., Toriumi, H., Yamada, S., Hoshino, H. and Suzuki, N. (2011) Astrocytes and pericytes 
cooperatively maintain a capillary-like structure composed of endothelial cells on gel 
matrix. Brain research, 1406, 74-83. 
Janaway, B. M., Simpson, J. E., Hoggard, N. et al. (2014) Brain haemosiderin in older people: 
pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) 
microbleeds. Neuropathology and applied neurobiology, 40, 258-269. 
Jellinger, K. A. (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta 
neuropathologica, 113, 349-388. 
Jokinen, H., Gouw, A. A., Madureira, S. et al. (2011) Incident lacunes influence cognitive 
decline: the LADIS study. Neurology, 76, 1872-1878. 
Jokinen, H., Ryberg, C., Kalska, H. et al. (2007) Corpus callosum atrophy is associated with 
mental slowing and executive deficits in subjects with age-related white matter 
hyperintensities: the LADIS Study. Journal of neurology, neurosurgery, and psychiatry, 
78, 491-496. 
Kalaria, R., Ferrer, I. and Love, S. (2015) Vascular Disease, Hypoxia and Related Conditions. 
In: Greenfield's Neuropathology, (P. A. Love S, Ironside J, Budka H ed.), Vol. 1, pp. 1-55. 
CRC Press, London. 
Kalaria, R. N. (2016) Neuropathological diagnosis of vascular cognitive impairment and 
vascular dementia with implications for Alzheimer's disease. Acta neuropathologica, 131, 
659-685. 
Hase Y et al , J Neurochem, submitted 
 
28 
 
Kalaria, R. N. and Ihara, M. (2013) Dementia: Vascular and neurodegenerative pathways-will 
they meet? Nature reviews. Neurology, 9, 487-488. 
Kalaria, R. N., Perry, R. H., O'Brien, J. and Jaros, E. (2012) Atheromatous disease in small 
intracerebral vessels, microinfarcts and dementia. Neuropathology and applied 
neurobiology, 38, 505-508. 
Kandiah, N., Goh, O., Mak, E., Marmin, M. and Ng, A. (2014) Carotid stenosis: a risk factor for 
cerebral white-matter disease. Journal of stroke and cerebrovascular diseases : the official 
journal of National Stroke Association, 23, 136-139. 
Kee Hyung, P., Lee, J. Y., Na, D. L. et al. (2011) Different associations of periventricular and 
deep white matter lesions with cognition, neuropsychiatric symptoms, and daily activities 
in dementia. Journal of geriatric psychiatry and neurology, 24, 84-90. 
Kitamura, A., Fujita, Y., Oishi, N. et al. (2012) Selective white matter abnormalities in a novel 
rat model of vascular dementia. Neurobiology of aging, 33, 1012 e1025-1035. 
Kitamura, A., Manso, Y., Duncombe, J. et al. (2017) Long-term cilostazol treatment reduces 
gliovascular damage and memory impairment in a mouse model of chronic cerebral 
hypoperfusion. Scientific reports, 7, 4299. 
Kobayashi, K., Hayashi, M., Nakano, H., Fukutani, Y., Sasaki, K., Shimazaki, M. and Koshino, 
Y. (2002) Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes 
in white matter lesions in Alzheimer's disease. Neuropathology and applied neurobiology, 
28, 238-251. 
Kovari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C. and Giannakopoulos, 
P. (2007) Cortical microinfarcts and demyelination affect cognition in cases at high risk for 
dementia. Neurology, 68, 927-931. 
Kraig, R. P. and Chesler, M. (1990) Astrocytic Acidosis in Hyperglycemic and Complete 
Ischemia. Journal of cerebral blood flow and metabolism : official journal of the 
International Society of Cerebral Blood Flow and Metabolism, 10, 104-114. 
Lammie, G. A., Brannan, F., Slattery, J. and Warlow, C. (1997) Nonhypertensive cerebral small-
vessel disease. An autopsy study. Stroke; a journal of cerebral circulation, 28, 2222-2229. 
Lampron, A., Larochelle, A., Laflamme, N. et al. (2015) Inefficient clearance of myelin debris 
by microglia impairs remyelinating processes. The Journal of experimental medicine, 212, 
481-495. 
Longstreth, W. T., Jr., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., 
Enright, P. L., O'Leary, D. and Fried, L. (1996) Clinical correlates of white matter findings 
Hase Y et al , J Neurochem, submitted 
 
29 
 
on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health 
Study. Stroke; a journal of cerebral circulation, 27, 1274-1282. 
Lundgaard, I., Osorio, M. J., Kress, B. T., Sanggaard, S. and Nedergaard, M. (2014) White 
matter astrocytes in health and disease. Neuroscience, 276, 161-173. 
Ma, J., Zhang, J., Hou, W. W. et al. (2015) Early treatment of minocycline alleviates white 
matter and cognitive impairments after chronic cerebral hypoperfusion. Scientific reports, 
5, 12079. 
Maclullich, A. M., Wardlaw, J. M., Ferguson, K. J., Starr, J. M., Seckl, J. R. and Deary, I. J. 
(2004) Enlarged perivascular spaces are associated with cognitive function in healthy 
elderly men. Journal of neurology, neurosurgery, and psychiatry, 75, 1519-1523. 
Maki, T., Ihara, M., Fujita, Y., Nambu, T., Harada, H., Ito, H., Nakao, K., Tomimoto, H. and 
Takahashi, R. (2011a) Angiogenic roles of adrenomedullin through vascular endothelial 
growth factor induction. Neuroreport, 22, 442-447. 
Maki, T., Ihara, M., Fujita, Y. et al. (2011b) Angiogenic and vasoprotective effects of 
adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in 
mice. Stroke; a journal of cerebral circulation, 42, 1122-1128. 
Maki, T., Maeda, M., Uemura, M. et al. (2015a) Potential interactions between pericytes and 
oligodendrocyte precursor cells in perivascular regions of cerebral white matter. 
Neuroscience letters, 597, 164-169. 
Maki, T., Takahashi, Y., Miyamoto, N., Liang, A. C., Ihara, M., Lo, E. H. and Arai, K. (2015b) 
Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-
basic-protein expressing oligodendrocytes under pathological conditions in vitro. Stem cell 
research, 15, 68-74. 
Makin, S. D., Turpin, S., Dennis, M. S. and Wardlaw, J. M. (2013) Cognitive impairment after 
lacunar stroke: systematic review and meta-analysis of incidence, prevalence and 
comparison with other stroke subtypes. Journal of neurology, neurosurgery, and 
psychiatry, 84, 893-900. 
Manso, Y., Holland, P. R., Kitamura, A. et al. (2017) Minocycline reduces microgliosis and 
improves subcortical white matter function in a model of cerebral vascular disease. Glia. 
Marner, L., Nyengaard, J. R., Tang, Y. and Pakkenberg, B. (2003) Marked loss of myelinated 
nerve fibers in the human brain with age. The Journal of comparative neurology, 462, 144-
152. 
Hase Y et al , J Neurochem, submitted 
 
30 
 
Matthews, F. E., Brayne, C., Lowe, J., McKeith, I., Wharton, S. B. and Ince, P. (2009) 
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research 
Council Cognitive Function and Ageing Study. PLoS medicine, 6, e1000180. 
McAleese, K. E., Firbank, M., Hunter, D. et al. (2013) Magnetic resonance imaging of fixed post 
mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and 
occipital white matter. Neuropathology and applied neurobiology, 39, 485-497. 
Miners, J. S., Schulz, I. and Love, S. (2017) Differing associations between Abeta accumulation, 
hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in 
the precuneus and parietal white matter in Alzheimer's disease. Journal of cerebral blood 
flow and metabolism : official journal of the International Society of Cerebral Blood Flow 
and Metabolism, 271678X17690761. 
Mitew, S., Hay, C. M., Peckham, H., Xiao, J., Koenning, M. and Emery, B. (2014) Mechanisms 
regulating the development of oligodendrocytes and central nervous system myelin. 
Neuroscience, 276, 29-47. 
Mitome-Mishima, Y., Miyamoto, N., Tanaka, R., Shimosawa, T., Oishi, H., Arai, H., Hattori, N. 
and Urabe, T. (2014) Adrenomedullin deficiency and aging exacerbate ischemic white 
matter injury after prolonged cerebral hypoperfusion in mice. BioMed research 
international, 2014, 861632. 
Miyamoto, N., Maki, T., Pham, L. D. et al. (2013a) Oxidative stress interferes with white matter 
renewal after prolonged cerebral hypoperfusion in mice. Stroke; a journal of cerebral 
circulation, 44, 3516-3521. 
Miyamoto, N., Maki, T., Shindo, A. et al. (2015) Astrocytes Promote Oligodendrogenesis after 
White Matter Damage via Brain-Derived Neurotrophic Factor. The Journal of 
neuroscience : the official journal of the Society for Neuroscience, 35, 14002-14008. 
Miyamoto, N., Pham, L. D., Hayakawa, K. et al. (2013b) Age-related decline in 
oligodendrogenesis retards white matter repair in mice. Stroke; a journal of cerebral 
circulation, 44, 2573-2578. 
Miyamoto, N., Pham, L. D., Maki, T., Liang, A. C. and Arai, K. (2014) A radical scavenger 
edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier 
breakdown in a mouse model of prolonged cerebral hypoperfusion. Neuroscience letters, 
573, 40-45. 
Mori, S., Sadoshima, S., Ibayashi, S., Lino, K. and Fujishima, M. (1994) Relation of cerebral 
blood flow to motor and cognitive functions in chronic stroke patients. Stroke; a journal of 
cerebral circulation, 25, 309-317. 
Hase Y et al , J Neurochem, submitted 
 
31 
 
Mueller, S. M. (1982) The blood-brain barrier in young spontaneously hypertensive rats. Acta 
neurologica Scandinavica, 65, 623-628. 
Nagelhus, E. A. and Ottersen, O. P. (2013) Physiological roles of aquaporin-4 in brain. 
Physiological reviews, 93, 1543-1562. 
Nahirnyj, A., Livne-Bar, I., Guo, X. and Sivak, J. M. (2013) ROS detoxification and 
proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature 
astrocyte activation. PloS one, 8, e83049. 
Nakaji, K., Ihara, M., Takahashi, C., Itohara, S., Noda, M., Takahashi, R. and Tomimoto, H. 
(2006) Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter 
lesions after chronic cerebral hypoperfusion in rodents. Stroke; a journal of cerebral 
circulation, 37, 2816-2823. 
Nave, K. A. and Werner, H. B. (2014) Myelination of the nervous system: mechanisms and 
functions. Annual review of cell and developmental biology, 30, 503-533. 
Nedergaard, M., Ransom, B. and Goldman, S. A. (2003) New roles for astrocytes: redefining the 
functional architecture of the brain. Trends Neurosci, 26, 523-530. 
Nishio, K., Ihara, M., Yamasaki, N. et al. (2010) A mouse model characterizing features of 
vascular dementia with hippocampal atrophy. Stroke; a journal of cerebral circulation, 41, 
1278-1284. 
Nitkunan, A., McIntyre, D. J., Barrick, T. R., O'Sullivan, M., Shen, Y., Clark, C. A., Howe, F. 
A. and Markus, H. S. (2006) Correlations between MRS and DTI in cerebral small vessel 
disease. NMR in biomedicine, 19, 610-616. 
Ovbiagele, B. and Saver, J. L. (2006) Cerebral white matter hyperintensities on MRI: Current 
concepts and therapeutic implications. Cerebrovascular diseases, 22, 83-90. 
Pantoni, L. (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics 
to therapeutic challenges. The Lancet. Neurology, 9, 689-701. 
Poggesi, A., Pantoni, L., Inzitari, D. et al. (2011) 2001-2011: A Decade of the LADIS 
(Leukoaraiosis And DISability) Study: What Have We Learned about White Matter 
Changes and Small-Vessel Disease? Cerebrovascular diseases, 32, 577-588. 
Pollock, H., Hutchings, M., Weller, R. O. and Zhang, E. T. (1997) Perivascular spaces in the 
basal ganglia of the human brain: their relationship to lacunes. Journal of anatomy, 191 ( 
Pt 3), 337-346. 
Popescu, B. F., Parisi, J. E., Cabrera-Gomez, J. A., Newell, K., Mandler, R. N., Pittock, S. J., 
Lennon, V. A., Weinshenker, B. G. and Lucchinetti, C. F. (2010) Absence of cortical 
demyelination in neuromyelitis optica. Neurology, 75, 2103-2109. 
Hase Y et al , J Neurochem, submitted 
 
32 
 
Prins, N. D. and Scheltens, P. (2015) White matter hyperintensities, cognitive impairment and 
dementia: an update. Nature reviews. Neurology, 11, 157-165. 
Qin, A. P., Liu, C. F., Qin, Y. Y., Hong, L. Z., Xu, M., Yang, L., Liu, J., Qin, Z. H. and Zhang, 
H. L. (2010) Autophagy was activated in injured astrocytes and mildly decreased cell 
survival following glucose and oxygen deprivation and focal cerebral ischemia. 
Autophagy, 6, 738-753. 
Rajani, R. M. and Williams, A. (2017) Endothelial cell-oligodendrocyte interactions in small 
vessel disease and aging. Clinical science, 131, 369-379. 
Reimer, M. M., McQueen, J., Searcy, L. et al. (2011) Rapid disruption of axon-glial integrity in 
response to mild cerebral hypoperfusion. The Journal of neuroscience : the official journal 
of the Society for Neuroscience, 31, 18185-18194. 
Richardson, W. D., Pringle, N., Mosley, M. J., Westermark, B. and Dubois-Dalcq, M. (1988) A 
role for platelet-derived growth factor in normal gliogenesis in the central nervous system. 
Cell, 53, 309-319. 
Rosenberg, G. A. (2017) Extracellular matrix inflammation in vascular cognitive impairment 
and dementia. Clinical science, 131, 425-437. 
Ryberg, C., Rostrup, E., Paulson, O. B. et al. (2011) Corpus callosum atrophy as a predictor of 
age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study 
cohort. Journal of the neurological sciences, 307, 100-105. 
Sachdev, P. S., Thalamuthu, A., Mather, K. A., Ames, D., Wright, M. J., Wen, W. and Team, O. 
C. R. (2016) White Matter Hyperintensities Are Under Strong Genetic Influence. Stroke; a 
journal of cerebral circulation, 47, 1422-1428. 
Saggu, R., Schumacher, T., Gerich, F., Rakers, C., Tai, K., Delekate, A. and Petzold, G. C. 
(2016) Astroglial NF-kB contributes to white matter damage and cognitive impairment in a 
mouse model of vascular dementia. Acta neuropathologica communications, 4, 76. 
Sahlas, D. J., Bilbao, J. M., Swartz, R. H. and Black, S. E. (2002) Clasmatodendrosis correlating 
with periventricular hyperintensity in mixed dementia. Annals of neurology, 52, 378-381. 
Salat, D. H., Tuch, D. S., Greve, D. N. et al. (2005) Age-related alterations in white matter 
microstructure measured by diffusion tensor imaging. Neurobiology of aging, 26, 1215-
1227. 
Sandoval, K. E. and Witt, K. A. (2008) Blood-brain barrier tight junction permeability and 
ischemic stroke. Neurobiology of disease, 32, 200-219. 
Hase Y et al , J Neurochem, submitted 
 
33 
 
Schmidt, R., Fazekas, F., Kapeller, P., Schmidt, H. and Hartung, H. P. (1999) MRI white matter 
hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology, 
53, 132-139. 
Schmidt, R., Ropele, S., Enzinger, C., Petrovic, K., Smith, S., Schmidt, H., Matthews, P. M. and 
Fazekas, F. (2005) White matter lesion progression, brain atrophy, and cognitive decline: 
the Austrian stroke prevention study. Annals of neurology, 58, 610-616. 
Seo, J. H., Miyamoto, N., Hayakawa, K., Pham, L. D., Maki, T., Ayata, C., Kim, K. W., Lo, E. 
H. and Arai, K. (2013) Oligodendrocyte precursors induce early blood-brain barrier 
opening after white matter injury. The Journal of clinical investigation, 123, 782-786. 
Shen, H., Hu, X., Liu, C., Wang, S., Zhang, W., Gao, H., Stetler, R. A., Gao, Y. and Chen, J. 
(2010) Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death 
and anti-inflammatory mechanisms. Neurobiology of disease, 37, 711-722. 
Shi, Y., Thrippleton, M. J., Makin, S. D., Marshall, I., Geerlings, M. I., de Craen, A. J., van 
Buchem, M. A. and Wardlaw, J. M. (2016) Cerebral blood flow in small vessel disease: A 
systematic review and meta-analysis. Journal of cerebral blood flow and metabolism : 
official journal of the International Society of Cerebral Blood Flow and Metabolism, 36, 
1653-1667. 
Shibata, M., Ohtani, R., Ihara, M. and Tomimoto, H. (2004) White matter lesions and glial 
activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke; a journal of 
cerebral circulation, 35, 2598-2603. 
Simpson, J. E., Fernando, M. S., Clark, L. et al. (2007a) White matter lesions in an unselected 
cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. 
Neuropathology and applied neurobiology, 33, 410-419. 
Simpson, J. E., Hosny, O., Wharton, S. B. et al. (2009) Microarray RNA expression analysis of 
cerebral white matter lesions reveals changes in multiple functional pathways. Stroke; a 
journal of cerebral circulation, 40, 369-375. 
Simpson, J. E., Ince, P. G., Higham, C. E. et al. (2007b) Microglial activation in white matter 
lesions and nonlesional white matter of ageing brains. Neuropathology and applied 
neurobiology, 33, 670-683. 
Simpson, J. E., Wharton, S. B., Cooper, J. et al. (2010) Alterations of the blood-brain barrier in 
cerebral white matter lesions in the ageing brain. Neuroscience letters, 486, 246-251. 
Sjobeck, M., Haglund, M. and Englund, E. (2005) Decreasing myelin density reflected 
increasing white matter pathology in Alzheimer's disease--a neuropathological study. 
International journal of geriatric psychiatry, 20, 919-926. 
Hase Y et al , J Neurochem, submitted 
 
34 
 
Skripuletz, T., Hackstette, D., Bauer, K. et al. (2013) Astrocytes regulate myelin clearance 
through recruitment of microglia during cuprizone-induced demyelination. Brain : a 
journal of neurology, 136, 147-167. 
Skrobot, O. A., Attems, J., Esiri, M. et al. (2016) Vascular cognitive impairment neuropathology 
guidelines (VCING): the contribution of cerebrovascular pathology to cognitive 
impairment. Brain : a journal of neurology. 
Tang, J. P., Xu, Z. Q., Douglas, F. L., Rakhit, A. and Melethil, S. (1993) Increased blood-brain 
barrier permeability of amino acids in chronic hypertension. Life sciences, 53, PL417-420. 
Taniguchi, M., Yamashita, T., Kumura, E. et al. (2000) Induction of aquaporin-4 water channel 
mRNA after focal cerebral ischemia in rat. Brain research. Molecular brain research, 78, 
131-137. 
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. 
E., Kukull, W. A. and Trojanowski, J. Q. (2013) Contribution of cerebrovascular disease in 
autopsy confirmed neurodegenerative disease cases in the National Alzheimer's 
Coordinating Centre. Brain : a journal of neurology, 136, 2697-2706. 
Tomimoto, H., Akiguchi, I., Suenaga, T., Nishimura, M., Wakita, H., Nakamura, S. and Kimura, 
J. (1996) Alterations of the blood-brain barrier and glial cells in white-matter lesions in 
cerebrovascular and Alzheimer's disease patients. Stroke; a journal of cerebral circulation, 
27, 2069-2074. 
Tomimoto, H., Akiguchi, I., Wakita, H., Suenaga, T., Nakamura, S. and Kimura, J. (1997) 
Regressive changes of astroglia in white matter lesions in cerebrovascular disease and 
Alzheimer's disease patients. Acta neuropathologica, 94, 146-152. 
Tomimoto, H., Ihara, M., Wakita, H., Ohtani, R., Lin, J. X., Akiguchi, I., Kinoshita, M. and 
Shibasaki, H. (2003) Chronic cerebral hypoperfusion induces white matter lesions and loss 
of oligodendroglia with DNA fragmentation in the rat. Acta neuropathologica, 106, 527-
534. 
Tomimoto, H., Lin, J. X., Matsuo, A., Ihara, M., Ohtani, R., Shibata, M., Miki, Y. and 
Shibasaki, H. (2004) Different mechanisms of corpus callosum atrophy in Alzheimer's 
disease and vascular dementia. Journal of neurology, 251, 398-406. 
Trigiani, L. J. and Hamel, E. (2017) An endothelial link between the benefits of physical 
exercise in dementia. Journal of cerebral blood flow and metabolism : official journal of 
the International Society of Cerebral Blood Flow and Metabolism, 37, 2649-2664. 
Turner, S. T., Jack, C. R., Fornage, M., Mosley, T. H., Boerwinkle, E. and de Andrade, M. 
(2004) Heritability of leukoaraiosis in hypertensive sibships. Hypertension, 43, 483-487. 
Hase Y et al , J Neurochem, submitted 
 
35 
 
Uemura, M. T., Ihara, M., Maki, T. et al. (2017) Pericyte-derived bone morphogenetic protein 4 
underlies white matter damage after chronic hypoperfusion. Brain pathology. 
van der Knaap, M. S. and Bugiani, M. (2017) Leukodystrophies: a proposed classification 
system based on pathological changes and pathogenetic mechanisms. Acta 
neuropathologica. 
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S. and Nabekura, J. (2009) Resting microglia 
directly monitor the functional state of synapses in vivo and determine the fate of ischemic 
terminals. The Journal of neuroscience : the official journal of the Society for 
Neuroscience, 29, 3974-3980. 
Wang, J., Yang, Z., Liu, C., Zhao, Y. and Chen, Y. (2013) Activated microglia provide a 
neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor 
necrosis factor-alpha secretion after subacute cerebral ischemia. International journal of 
molecular medicine, 31, 172-178. 
Wardlaw, J. M., Doubal, F. N., Valdes-Hernandez, M., Wang, X., Chappell, F. M., Shuler, K., 
Armitage, P. A., Carpenter, T. C. and Dennis, M. S. (2013a) Blood-brain barrier 
permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. 
Stroke; a journal of cerebral circulation, 44, 525-527. 
Wardlaw, J. M., Smith, E. E., Biessels, G. J. et al. (2013b) Neuroimaging standards for research 
into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. 
Neurology, 12, 822-838. 
Washida, K., Ihara, M., Nishio, K. et al. (2010) Nonhypotensive dose of telmisartan attenuates 
cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma 
activation in mice with chronic cerebral hypoperfusion. Stroke; a journal of cerebral 
circulation, 41, 1798-1806. 
Weiss, N., Miller, F., Cazaubon, S. and Couraud, P. O. (2009) The blood-brain barrier in brain 
homeostasis and neurological diseases. Biochimica et biophysica acta, 1788, 842-857. 
Weller, R. O., Subash, M., Preston, S. D., Mazanti, I. and Carare, R. O. (2008) Perivascular 
drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid 
angiopathy and Alzheimer's disease. Brain pathology (Zurich, Switzerland), 18, 253-266. 
Wolf, G., Lotan, A., Lifschytz, T. et al. (2017) Differentially Severe Cognitive Effects of 
Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation 
and Microglia Activation. Frontiers in aging neuroscience, 9, 191. 
Yamashita, T., Kamiya, T., Deguchi, K. et al. (2009) Dissociation and protection of the 
neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. Journal of 
Hase Y et al , J Neurochem, submitted 
 
36 
 
cerebral blood flow and metabolism : official journal of the International Society of 
Cerebral Blood Flow and Metabolism, 29, 715-725. 
Yamauchi, H., Fukuyama, H. and Shio, H. (2000) Corpus callosum atrophy in patients with 
leukoaraiosis may indicate global cognitive impairment. Stroke; a journal of cerebral 
circulation, 31, 1515-1520. 
Yang, Z., Zhang, N., Shen, H., Lin, C., Lin, L. and Yuan, B. (2014) Microglial activation with 
reduction in autophagy limits white matter lesions and improves cognitive defects during 
cerebral hypoperfusion. Current neurovascular research, 11, 223-229. 
Yao, Y., Chen, Z. L., Norris, E. H. and Strickland, S. (2014) Astrocytic laminin regulates 
pericyte differentiation and maintains blood brain barrier integrity. Nature 
communications, 5, 3413. 
Zambenedetti, P., Schmitt, H. P. and Zatta, P. (2002) Metallothionein I-II immunocytochemical 
reactivity in Binswanger's encephalopathy. Journal of Alzheimer's disease : JAD, 4, 459-
466. 
Zhai, Y., Yamashita, T., Nakano, Y., Sun, Z., Morihara, R., Fukui, Y., Ohta, Y., Hishikawa, N. 
and Abe, K. (2016) Disruption of White Matter Integrity by Chronic Cerebral 
Hypoperfusion in Alzheimer's Disease Mouse Model. Journal of Alzheimer's disease : 
JAD, 52, 1311-1319. 
 
 
  
Hase Y et al , J Neurochem, submitted 
 
37 
 
Table 1:  Neuroimaging and pathological features associated with WM Degeneration and 
Dementia 
Feature Methodological details Degree/ 
Frequency 
of change                    
Association 
with 
CI/Dementia 
WMH (T2 weighted MRI) Total or ROI (PWML, 
DWML) WMH volumes 
assessed by voxels  
Increased 
with age 
Strong 
Vascular pathology score 
(range)‡ 
Pathological scoring system, 1-
20. 
Score of 
>10 
Weak  
White Matter Score WM pathology scoring system, 
0-3. 
Scores 2-3 Moderate 
Myelin Index (MI); myelin 
loss (demyelination) 
Myelin density scoring system, 
quartiles. 
MI score of 
>50%  
Strong  
Sclerotic Index (SI) Arteriolosclerosis measuring 
system  
SI > 300μm  Unclear  
Arteriolosclerosis Semi-quantitative scoring 
system (0-3) 
Score of 2-3 Weak  
Hyalinosis, lipohyalinosis, 
fibroid necrosis 
WM, cortical and subcortical 
grey matter 
 Moderate Unknown  
WM Endothelium Density of GLUT1 
immunostain 
Moderate  Weak  
Basement membranes Density of COL4 immunostain Thickening Weak  
Pericytes Counts in COL4 
immunostained sections 
Loss Strong  
Oligodendrocyte changes Density in H&E sections High Unclear 
Oligodendrocyte precursor 
cells (OPCs) 
Density of GLUT1 
immunostain 
Low Unknown 
Axonal loss Density length determined by 3 
D stereology 
Low Unclear 
Axonal abnormalities SMI32 and APP immunostains Variable Moderate 
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Complete infarctions  
(macroscopic), arterial 
territorial infarctions 
Cortical and subcortical 
regions in H&E stained 
sections 
Moderate Weak 
Lacunar infarcts  Counts in H&E sections Moderate Moderate 
Small or microinfarcts Counts in H&E sections High  Strong  
Microbleeds  Counts in H&E sections Low Unknown 
Microspongy form change Semi-quantitative scoring 
system (0-3) 
Moderate  Unknown 
Perivascular spacing  Semi-quantitative scoring 
system (0-3) 
Moderate  Moderate 
Gliosis: astrocytosis  Density of GFAP, CD68  
immunostain 
Variable  Moderate 
Microglia/Macrophages Density of CD68  immunostain  Moderate Unknown  
 
Data summarised from several sources (Craggs et al. 2013, Deramecourt et al. 2012, Ihara et al. 
2010, Lammie et al. 1997, Skrobot et al. 2016).  ‡Vascular pathology scores were derived as 
described previously (Deramecourt et al. 2012).  Abbreviations: DWML, deep white matter 
lesions; MRI, magnetic resonance imaging; PWML, periventricular lesions; ROI, region(s) of 
interest; WMH, white matter hyperintensity; WM, white matter. 
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Figure legends 
Figure 1:  White matter lesions visualised by conventional MRI and histopathological 
staining in an 80 year old man with vascular cognitive impairment.  A-B, Confluent 
WMH seen in the axial planes of 2-T Weighted MRI from two different subjects.  
Areas of hypersignals can be seen in the deep and perivascular WM (*).   C, WM 
rarefaction and myelin loss in the deep WM.  Arrows show perivascular spacing 
around two arterioles.  D, Partial image of a lacunar infarct in the temporal lobe WM 
H&E stained section showing.  E, A microinfarct (arrow) in the frontal lobe WM.  F, 
a microaneurysm with hyalinised vessels and microbleeds in WM of the parietal lobe.  
Stains: C, luxol fast blue stained section;  D-F, H&E stained sections.  Magnification 
bar: C=150m; D=250m; E,F=100m. 
Figure 2:  Figure showing increasing loss of myelin density in different disorders 
with increasing vascular pathology.  Means (SE) for n=10-12 subjects show 
calculated myelin index (MI) values of the frontal WM in controls and patients with 
various dementias.  Mean MI values for subjects were significantly different from 
Controls †P=0.034 and from undamaged myelin *P<0.01;  Abbreviations: Controls, 
aged controls, PSND, post-stroke non-demented, PSD, post-stroke dementia, VaD, 
vascular dementia, Mix, mixed dementia, AD, Alzheimer’s disease. 
Figure 3:  Schematic diagram of the interactions between major cellular components 
within the brain WM.   WM microvessels are associated with astrocytes, 
oligodendrocyte precursor cells (OPCs), microglia/macrophages and pericytes.  The 
gliovascular unit of the WM is formed by astrocyte end-feet juxtaposed to the WM 
endothelium and glial and endothelial cells functionally interact with each other in a 
paracrine manner. Together with astrocytes, pericytes are important players within the 
gliovascular unit modulating vessel diameters. The oligovascular niche is formed by 
OPCs and the endothelium where an exchange of soluble signals (e.g. trophic factors 
or chemical messengers) plays an important role in sustaining oligodendrocyte 
homeostasis and WM integrity.  Microglial processes are closely associated with the 
brain endothelium in a fraction of cerebral microvessels 
Figure 4: Images from C57BL/6J mice studies showing astrocyte degeneration in the 
WM.  GFAP (astrocyte marker) and aquaporin-4 (AQP4) distribution in the corpus 
callosum. A-B, Representative images of double immunofluorescent staining for 
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GFAP and AQP4 in the corpus callosum.  In sham, AQP4 was normally distributed 
around the vessels within the astrocytic end-feet (A) (arrow heads), whereas in 
hypoperfused mice (BCAS mice), AQP4 was abnormally distributed at the periphery 
of GFAP-positive astrocytes or clasmatodendrocytes (damaged astrocytes) (B). Scale 
bar represents 10µm.   
 
